+Compare
PODD
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
11.17B

PODD Insulet Corp Forecast, Technical & Fundamental Analysis

a manufacturer of insulin infusion systems

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for PODD with price predictions
08:00 PM EDT Sep 20, 2023

PODD in -4.45% downward trend, declining for three consecutive days on September 21, 2023

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where PODD declined for three days, in of 285 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for PODD entered a downward trend on September 21, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for PODD just turned positive on August 31, 2023. Looking at past instances where PODD's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PODD advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

PODD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PODD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.161) is normal, around the industry mean (24.980). P/E Ratio (178.571) is within average values for comparable stocks, (80.233). Projected Growth (PEG Ratio) (0.521) is also within normal values, averaging (6.278). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (7.675) is also within normal values, averaging (58.283).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.39B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -4%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -7%. AVGR experienced the highest price growth at 135%, while HSCS experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 25%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was 51%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 66
SMR Rating: 83
Profit Risk Rating: 88
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

PODD is expected to report earnings to rise 5.47% to 40 cents per share on November 02

Insulet Corp PODD Stock Earnings Reports
Q3'23
Est.
$0.40
Q2'23
Beat
by $0.12
Q1'23
Beat
by $0.12
Q4'22
Beat
by $0.34
Q3'22
Beat
by $0.30
The last earnings report on August 08 showed earnings per share of 37 cents, beating the estimate of 25 cents. With 1.08M shares outstanding, the current market capitalization sits at 11.17B.
A.I. Advisor
published General Information

General Information

a manufacturer of insulin infusion systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
100 Nagog Park
Phone
+1 978 600-7000
Employees
2600
Web
https://www.insulet.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIPS14.830.33
+2.28%
Vipshop Holdings Limited
SCX10.96-0.03
-0.27%
LS Starrett Company (The)
CDNA7.66-0.09
-1.16%
CareDx
IVT24.48-0.33
-1.33%
InvenTrust Properties Corp
SLRX0.72-0.05
-6.85%
Salarius Pharmaceuticals

PODD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PODD has been loosely correlated with TMDX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then TMDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PODD
1D Price
Change %
PODD100%
-2.64%
TMDX - PODD
50%
Loosely correlated
-2.96%
DXCM - PODD
48%
Loosely correlated
-1.77%
RVTY - PODD
45%
Loosely correlated
+0.93%
ILMN - PODD
42%
Loosely correlated
-0.67%
ABT - PODD
41%
Loosely correlated
-0.79%
More

Groups containing PODD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PODD
1D Price
Change %
PODD100%
-2.64%
medical research
(undefined stocks)
51%
Loosely correlated
-1.02%
medical service
(undefined stocks)
50%
Loosely correlated
-1.17%
Medical Specialties
(undefined stocks)
47%
Loosely correlated
-0.72%
Medical Specialties
(undefined stocks)
47%
Loosely correlated
-0.72%